X0607 3/A 2026-03-18 2026-03-18 0 0001075880 KAZIA THERAPEUTICS LTD KZIA 0001704021 Friend John E. II true THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVE SYDNEY, NSW AUSTRALIA C3 2000 AUSTRALIA false true false false Chief Executive Officer American Depositary Share Option (Right to Buy) 18.85 2027-07-22 American Depositary Shares 30000 D The American Depositary Shares ("ADSs") subject to the option ("ADS option") vest in equal quarterly installments over three years beginning on April 22, 2024, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The ADS option was granted on July 22, 2024. Each ADS option is convertible into ADSs upon exercise. Each ADS may be represented by 500 ordinary shares of the Issuer, no par per share (the "Ordinary Shares"), at any time, upon the holder's election to surrender the ADSs and withdraw the respective number of Ordinary Shares. The ADSs have no expiration date. This Form 3/A is being filed to correct the exercise price of the ADS option granted on July 22, 2024. /s/ Jeffrey Bonacorda, Attorney-in-Fact 2026-04-09